Page last updated: 2024-11-05

tripelennamine and Deficiency Diseases

tripelennamine has been researched along with Deficiency Diseases in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Deficiency Diseases: A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Patients with hereditary angioneurotic edema are unresponsive to intradermal injections of C'1 esterase immediately after attacks."1.25Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema. ( Donaldson, VH; Klemperer, MR; Rosen, FS, 1968)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klemperer, MR1
Donaldson, VH1
Rosen, FS1

Other Studies

1 other study available for tripelennamine and Deficiency Diseases

ArticleYear
Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.
    The Journal of clinical investigation, 1968, Volume: 47, Issue:3

    Topics: Adult; Angioedema; Antigen-Antibody Reactions; Cell Membrane Permeability; Complement System Protein

1968